Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2019

Mar 7, 2019

29821_dirs_2019-03-07_22aad5e0-c386-4b34-9bc1-0ce4bee8b5b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-03-06

Reporting Person: Pierce David A (EVP,Pres MedSurg)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-03-06 Common Stock S 1357.0000 $40.2500 Disposed 38940.0000 Direct

Footnotes

F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.